Abstract
Tissue obtained from biobanks is frequently employed in biomarker studies. Biomarkers define objective, measurable characteristics of biological and biomedical procedures and have been used as indicators of clinical outcome. This article outlines some of the steps scientists should consider when embarking on biomarker research in cancer research using samples from biobanks and the importance and challenges of linking clinical data to biological samples.
| Original language | English |
|---|---|
| Number of pages | 6 |
| Journal | Biomarker Insights |
| Volume | 16 |
| Early online date | 20 Apr 2021 |
| DOIs | |
| Publication status | Published - 2021 |
Bibliographical note
Funding:The author disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The author receives funding from The University of Aberdeen Development Trust, Breast Cancer Now, Breast Cancer UK, Animal Free Research UK, Friends of Anchor and NC3Rs.
Keywords
- biomarker
- biobank
- cancer
- outcome
- data
- informatics
Access to Document
- Speirs_BI_Quality_Considerations_When_VOR
https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).